Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Sequencing of AsPC-1 cells with CYP3A5 expression modulation

ABSTRACT: Sequencing of AsPC-1 cells with CYP3A5 expression modulation

PROVIDER: PRJNA627104 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR11579180_1.fastq.gz	Fastqsanger.gz
	SRR11579180_2.fastq.gz	Fastqsanger.gz
	SRR11579181_1.fastq.gz	Fastqsanger.gz
	SRR11579181_2.fastq.gz	Fastqsanger.gz
	SRR11579182_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 24

Similar Datasets

Sequencing of AsPC-1 cells with CYP3A5 expression modulation

Project description:Purpose: To understand the transcriptome-wide effect of CYP3A5 knockdown or over-expression in AsPC-1 cells

2024-04-17 | GSE149000 | GEO

Gene expression from AsPC-1 cells treated with PTC596 and DMSO

Project description:This study examines the transcriptional changes invoked by the novel anti-cancer agent PTC596 in AsPC-1 pancreatic cancer cells as compared to DMSO.

2019-06-11 | GSE118441 | GEO

Genome-wide expression analysis of overexpressing Ctrl and PRLR-SF AsPC-1 cells

Project description:The study is to explore differentially expressed genes in AsPC-1 cells overexpressing Ctrl or PRLR-SF.

2020-10-24 | GSE159917 | GEO

MiRNA microarray of overexpression Ctrl and PRLR AsPC-1 cells.

Project description:The study is to explore differentially expressed miRNAs in AsPC-1 cells overexpressing Ctrl or PRLR.

2022-10-14 | GSE215273 | GEO

Gene expression from AsPC-1 cells treated with PTC596 and DMSO

Project description:Gene expression from AsPC-1 cells treated with PTC596 and DMSO

| PRJNA485679 | ENA

CYP3A5 Gene Expression is Associated with Early Recurrence of Non-small Cell Lung Cancer

Project description:Study to identify genes associated with NSCLC recurrence in patients not receiving adjuvant chemotherapy. Purpose: Recent clinical trials suggest improvement in survival with adjuvant chemotherapy in non-small cell lung cancer (NSCLC). This study's aim is to identify genes associated with NSCLC recurrence in patients not receiving adjuvant chemotherapy. Experimental design: Banked NSCLC tumors of patients who underwent resection of stage Ia-IIIb disease were identified. Patients were stratified into two groups: recurrent (R, n=11) or non-recurrent (NR, n=16) 2 years after surgery. Microarray profiling and Cox multivariate analysis were performed. Conclusion: Increased CYP3A5 gene expression correlates with NSCLC recurrence and promotes proliferation through mechanisms that may involve, in part, CYP3A5 epoxygenase activity. Keywords: comparison of gene expression profiles for recurrent and non-recurrent cancer

2009-12-01 | GSE9971 | GEO

Sequencing of commercially-available pancreatic cancer cell lines reveals selective CYP3A5 overexpression among xenobiotic-metabolizing CYPs.

Project description:Purpose: To know the expression of all cytochrome P450 (CYP) enzymes and related drug metabolizing enzymes in pancreatic cancer models Methods: We obtained expression profiles of 8 commercially-available pancreatic cancer cell lines and one non-cancerous immortalized cell line by RNA-sequencing. The pancreatic cancer cells were compared among themselves and to the non-cancerous control cells. Results: We confirmed reports that CYP3A5 is highly overexpressed in pancreatic cancer models, and additionally report that known xenobiotic-metabolizing CYPs are lowly expressed in comparison.

2020-03-01 | GSE138437 | GEO

Transcription profiling on non-small cell lung cancer samples reveals CYP3A5 gene expression is associated with early recurrence

Project description:Study to identify genes associated with NSCLC recurrence in patients not receiving adjuvant chemotherapy. Purpose: Recent clinical trials suggest improvement in survival with adjuvant chemotherapy in non-small cell lung cancer (NSCLC). This study's aim is to identify genes associated with NSCLC recurrence in patients not receiving adjuvant chemotherapy. Experimental design: Banked NSCLC tumors of patients who underwent resection of stage Ia-IIIb disease were identified. Patients were stratified into two groups: recurrent (R, n=11) or non-recurrent (NR, n=16) 2 years after surgery. Microarray profiling and Cox multivariate analysis were performed. Conclusion: Increased CYP3A5 gene expression correlates with NSCLC recurrence and promotes proliferation through mechanisms that may involve, in part, CYP3A5 epoxygenase activity. Experiment Overall Design: comparison of gene expression profiles for recurrent and non-recurrent cancer

2009-12-14 | E-GEOD-9971 | biostudies-arrayexpress

Effect of depletion of HMOX1 on gene expression of AsPC-1 cells.

Project description:Effect of depletion of HMOX1 on gene expression of AsPC-1 cells.

| PRJNA1007732 | ENA

MiRNA microarray of overexpression Ctrl and PRLR AsPC-1 cells.

Project description:MiRNA microarray of overexpression Ctrl and PRLR AsPC-1 cells.

| PRJNA889503 | ENA